Results 41 to 50 of about 59,535 (286)
Predictors of intracranial hemorrhage in neonatal patients on extracorporeal membrane oxygenation
Scientific Reports, 2023 Extracorporeal membrane oxygenation (ECMO) is a life-supportive treatment in neonatal patients with refractory lung and/or heart failure. Intracranial hemorrhage (ICH) is a severe complication and reliable predictors are warranted. The aims of this study
Sara Wood +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 Background: Mortality of patients suffering from critical illness has been dramatically improved with advanced technological development of extracorporeal membrane oxygenation (ECMO) therapy.
Yu Zheng +19 more
doaj +1 more source
A Review of the Role of Artificial Intelligence in Patients on Extracorporeal Membrane Oxygenation: A Scoping Review Study. [PDF]
Health Sci RepABSTRACT Background and Aims ECMO is used to deliver cardiopulmonary support in extreme failure where standard therapies are unfruitful. Although ECMO is associated with high costs and significant risks, advances in technology and clinical management have improved its safety and patient outcomes. AI/ML may provide decision support through data analysis
Asadi Z +4 more
europepmc +2 more sources
Advanced Materials, EarlyView.Additively manufactured triply periodic minimal surface (TPMS) membranes offer an architecture‐driven alternative to hollow fiber bundles in artificial lungs. Multiphysics simulations and endothelialized prototypes show that the 3D‐printable membrane architecture improves gas exchange, blood flow distribution, and hemocompatibility, enabling ...
Michael Pflaum +14 more
wiley +1 more source
Additional file 2: Table S6. of Microcirculatory assessment of patients under VA-ECMO
, 2016 The median values of administered drugs, blood transfusions, and laboratory parameters at VA-ECMO insertion within 24Â h (T1), 2â3 days after initiation of VA-ECMO (T2), and 5â6 days after initiation of VA-ECMO (T3).
Kadir Caliskan (3441230) +10 more
core +1 more source
Updated COVID‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions
Arthritis &Rheumatology, EarlyView.Objective We aimed to assess the association between COVID‐19 vaccination status and COVID‐19‐related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECMO), and death in people with autoimmune rheumatic conditions. Methods We conducted a retrospective cohort study using National Clinical Cohort Collaborative
Lesley E. Jackson +127 more
wiley +1 more source
Revista Colombiana de CardiologíaEl uso de soporte vital extracorpóreo es una opción en pacientes con shock cardiogénico secundario a insuficiencia ventricular derecha y tromboembolia pulmonar.
Leonardo A. Salazar-Rojas +3 more
doaj +1 more source
Scientific Reports, 2022 To determine the incidence and identify predictors of brain infarctions (BI) in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). We performed a retrospective cohort study at ECMO Centre Karolinska, Stockholm, Sweden.
Sarah Kopfer +6 more
doaj +1 more source
Cefepime exposure in prolonged or intermittent infusion in critically ill children
British Journal of Clinical Pharmacology, EarlyView.Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika +12 more
wiley +1 more source
Secondary Infections in Patients with Extremely Severe COVID-19 During ECMO Therapy
Общая реаниматология, 2023 Up to 70% of patients hospitalized for COVID-19 need respiratory support, up to 10% need high-flow oxygen therapy, non-invasive and invasive ventilation. However, standard methods of respiratory support are ineffective in 0.4-0.5% of patients. In case of
S. S. Andreev +3 more
doaj +1 more source